Navitas stock soars as company advances 800V tech for NVIDIA AI platforms
Odyssey Health, Inc. (OTCQB:ODYY) announced it has entered into a promissory note agreement with Peter D’Arruda, an accredited private investor. According to a statement filed with the Securities and Exchange Commission, the agreement was executed Friday and is effective as of October 1, 2025.
Under the terms of the agreement, Odyssey Health received $100,000 in funding from the investor. The promissory note carries a one-year term and bears interest at an annual rate of 18%. In connection with the note, Odyssey Health also issued a warrant to D’Arruda to purchase 100,000 shares of the company’s common stock at a price of $0.10 per share.
The transaction creates a direct financial obligation for the company. Details of the agreement, including the promissory note and warrant, were included as exhibits in the SEC filing.
This report is based on a press release statement and information contained in the company’s SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.